Procter & Gamble (PG) EBITDA (2008 - 2026)
Procter & Gamble (PG) EBITDA from Sep 30, 2008 to Mar 31, 2026. The TTM Procter & Gamble (PG) EBITDA is $23B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Procter & Gamble (PG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.90% |
| 3 Years TTM | +4.32% |
| 5 Years TTM | +2.54% |
| 10 Years TTM | +3.30% |
| All Time TTM | +8.04% |
Annual EBITDA change of Procter & Gamble (PG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $5.36B | -76.99% |
| 2025 | $23B | +8.66% |
| 2024 | $21B | +2.84% |
| 2023 | $21B | +1.11% |
| 2022 | $21B | -0.49% |
| 2021 | $21B | +10.70% |
| 2020 | $19B | +420.99% |
| 2019 | $3.59B | +12.49% |
| 2018 | $3.19B | +28.02% |
| 2017 | $2.50B | -55.29% |
| 2016 | $5.58B | +74.05% |
| 2015 | $3.21B | +35.16% |
| 2014 | $2.37B | -57.89% |
| 2013 | $5.63B | +38.85% |
| 2012 | $4.06B | -32.57% |
| 2011 | $6.02B | +80.53% |
| 2010 | $3.33B | -48.42% |
| 2009 | $6.46B | +29.14% |
| 2008 | $5B | N/A |
Comparison Procter & Gamble (PG) five years EBITDA CAGR with competitors
Procter & Gamble (PG) five years EBITDA CAGR is 2.54%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| IPAR | Inter Parfums Inc | 34.75% | +1266.30% |
| ELF | e.l.f. Beauty Inc | 34.64% | +1261.87% |
| EWCZ | European Wax Center Inc - Class A | 29.55% | +1061.92% |
| SKIN | Beauty Health Company (The) - Class A | 26.39% | +937.74% |
| SLSN | Solesence Inc | 25.67% | +909.22% |
| MAGN | Magnera Corp | 17.94% | +605.26% |
| UL | Unilever plc | 17.09% | +571.87% |
| SPB | Spectrum Brands Holdings Inc | 8.71% | +242.36% |
| HNST | Honest Company Inc (The ) | 6.53% | +156.75% |
| ACU | Acme United Corp | 5.15% | +102.56% |
| CHD | Church & Dwight Co. Inc | 1.83% | -28.16% |